MariMed PP&E per Employee
PP&E per Employee of MariMed (MRMD) as of Aug 7, 2026.
Get this data via API
Financial Data API
PP&E per Employee
0.00USD
Last updated:
PP&E per Employee of MariMed is 2026 0.00 USD. PP&E per Employee of MariMed was 2025 0.00 USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
MariMed Stock analysis
What does MariMed do? Marimed Inc is a leading company in the development of medical cannabis and hemp products. The company was founded in 2011 and has since made a name for itself through its innovative products and its focus on research and development of plant-based products.
Marimed Inc's business model is based on the research, development, and marketing of cannabis products. The company focuses on the development of medical cannabis products as well as the trade in hemp products. The product range includes oils, tinctures, capsules, vaporizers, and other electronic devices.
The various divisions of Marimed Inc include research and development, marketing, distribution, and licensing of medical cannabis. As a fully integrated company, Marimed Inc has its own cultivation, processing, and shipping infrastructure to ensure smooth delivery of high-quality cannabis products.
Another focus of the company is research, which focuses on the development of new cannabinoid compounds for the treatment of diseases such as epilepsy, inflammation, and arthritis. Thanks to this research, new products are constantly being developed to guarantee customers high effectiveness and quality.
An important factor for the success of Marimed Inc is its responsibility towards the environment and society. The company places great value on working sustainably and environmentally friendly, as well as convincing society of the benefits of medical cannabis products.
Among the products offered by Marimed Inc are the products of the Betty's Eddies brand. These products are specifically designed for patients suffering from ailments such as anxiety, insomnia, and pain. Betty's Eddies guarantees high effectiveness and a pleasant taste with its products.
Another product offered by Marimed Inc is the MariCann Vaporizer System. The vaporizer is a fast and easy way to consume medical cannabis without burdening the body. The device is suitable for both medical cannabis patients and recreational users.
Marimed Inc is a company that is always looking for new solutions and innovations to offer customers the best possible quality. The company is heavily involved in research and development to improve the quality of its products and promote the positive effects of medical cannabis on society. Marimed Inc is a company that can be trusted when it comes to medical cannabis and other hemp products. MariMed is one of the most popular companies on Eulerpool.
Frequently Asked Questions about MariMed stock
On Eulerpool you can find the complete historical development of PP&E per Employee MariMed since 2006 – with annual values, charts, and detailed analysis.
PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.
PP&E per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's MariMed historically and in real time.
Access this data via the Eulerpool API
Workforce — MariMed
All Key Metrics — MariMed
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth